Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|February 22, 2021
Beyond Andromeda: Improving Therapy for Light Chain AmyloidosisGregory P Kaufman, Claudio Cerchione
Journal of Cancer Research and Clinical Oncology|April 28, 2019
Immune checkpoint inhibitor therapy and myocarditis: a systematic review of reported casesSuheil Albert Atallah-Yunes, Anis John Kadado, Gregory P Kaufman, et al.
Blood|June 16, 2017
Daratumumab yields rapid and deep hematologic responses in patients with heavily pretreated AL amyloidosisGregory P Kaufman, Stanley L Schrier, Richard A Lafayette, et al.
European Journal of Haematology|October 15, 2013
Progressive multifocal leukoencephalopathy: a rare infectious complication following allogeneic hematopoietic cell transplantation (HCT)Gregory P Kaufman, Allen J Aksamit, Christopher J Klein, et al.
British Journal of Haematology|July 6, 2013
The novel proteasome inhibitor carfilzomib induces cell cycle arrest, apoptosis and potentiates the anti-tumour activity of chemotherapy in rituximab-resistant lymphomaJuan J Gu, Francisco J Hernandez-Ilizaliturri, Gregory P Kaufman, et al.
Blood Advances|February 7, 2020
Organ responses with daratumumab therapy in previously treated AL amyloidosisAlfred Chung, Gregory P Kaufman, Surbhi Sidana, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 2, 2021
Human herpesvirus 6 myelitis after chimeric antigen receptor T-cell therapyGuy Handley, Fareed Khawaja, Divya S Kondapi, et al.
Frontiers in Cardiovascular Medicine|July 16, 2021
Cardiac Magnetic Resonance Predicting Outcomes Among Patients at Risk for Cardiac AL AmyloidosisAli M Agha, Nicolas Palaskas, Amit R Patel, et al.
Pageof 2